Definitive Contract 00261199209D261925404
Award Date 9/30/92
Potential Completion Date 9/29/11
Potential Value $51M
Federal Agency
Ultimate Awardee
NAICS Category
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Los Angeles, CA 90095, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California, Davis (UC Davis) for early-stage therapeutic development with a focus on Phase II clinical trials. The $34,176,737.26 definitive cost-reimbursement contract was awarded on January 1, 2006 with a period of performance through February 20, 2015. The contract did not have a small business set-aside. UC Davis, a major public research...
- <p>This is a federal contract award from the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract, valued at $13,911,788.38, was awarded to the Cancer Prevention Institute of California to provide cancer information services. The contract type is Cost Plus Fixed Fee, and the period of performance extends from January 15, 2005, to January 14, 2010. This contract is not associated with any set-aside program.</p>
- This federal contract award was made by a U.S. government agency to the University of California as the prime contractor, with no set-aside designation. The $3,590,450.00 definitive contract with cost-no-fee pricing was completed on March 30, 2007. The University of California is part of the State of California Controller's Office, a U.S. state government entity, which has received several other federal grants and cooperative agreements for technology support, consulting services, product...
- <p>This is a definitive cost-no-fee contract awarded by the National Cancer Institute, a civilian agency, to Georgetown University Inc. on September 15, 1992. The contract, valued at $540,188,796.00, is for TAS PLCO/NLST FY2010 FUNDING and has a completion date of January 31, 2012. The contract does not have a set-aside designation. The National Cancer Institute is the funding agency for this award, which is likely related to the agency's cancer research and clinical trials programs.</p>
- This is a prime contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California Irvine (UC Irvine) for Phase I and II clinical trials of cancer chemopreventive agents. The $13,886,589.26 definitive contract does not have a set-aside designation, as UC Irvine was selected based on its extensive research capabilities and expertise in biomedical sciences. The contract supports the development of novel cancer prevention...
- This is a $11,572.34 firm fixed-price purchase order contract for laboratory testing services awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. government. The contract was awarded on September 10, 2024 to the Regents of the University of Michigan, doing business as the University of Michigan. The contract has an ultimate completion date of February 27, 2025 and does not utilize any set-aside designations. The University of Michigan is a U.S. state government...
- The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $451,414 cost-no-fee delivery order contract to the California Department of Public Health to provide Support Services for Oversight of SEER*DMS Migration for All Three California Surveillance, Epidemiology, and End Results Registries. The contract period of performance is from November 15, 2022 through December 14, 2024. The place of performance is...
- <p>The National Cancer Institute awarded a purchase order to the University of California, Davis Veterinary Genetics Laboratory for $5,000.00 on September 15, 2017, for CALUX analysis of non-UC human serum samples in support of the National Cancer Institute's Center for Cancer Research. Work is performed in Davis, California. The order carries a firm fixed price, with an ultimate completion date of September 14, 2018.</p>
- This is a federal contract award from the National Cancer Institute, a civilian agency, to provide STATE CANCER POLICY DATABASE SUPPORT SERVICES. The contract has a ceiling value of $29,543,490.00 and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The award was made on September 15, 2002 with a completion date of September 15, 2007. The contract does not have a set-aside designation. The prime contractor is No Data From D And B, and the place of performance is Silver Spring,...
- The federal contract award HHSN261200544000C was granted by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA), doing business as the Office of Research Administration. The contract is for the "CALIFORNIA HEALTH INTERVIEW SURVEY" with a ceiling value of $32,418,504.00. The contract is a definitive contract with a cost-no-fee pricing type, and has a completion date of...